A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis
Journal for Oto-Rhino-Laryngology, Head and Neck Surgery, 08/15/2011Han D et al.
Both azelastine hydrochloride nasal spray(ANS) and levocabastine hydrochloride nasal spray(LNS) were effective and safe in the treatment of moderate–to–severe persistent allergic rhinitis. Moreover, LNS reached a higher symptom relief rate within 30 min of administering the first dose.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.